David A. Sanan

5.9k citations

41 papers · 4.9k indexed · 2 hit papers · h-index 32

Impact in

Biochemistry top 0.5%
- Lipid metabolism and biosynthesis
Physiology top 1%
- Alzheimer's disease research and treatments
- Adipose Tissue and Metabolism

Papers in

Immunology and Allergy 6
- Cell Adhesion Molecules Research 6
Hematology 6
- Platelet Disorders and Treatments 5

Co-authors: Robert W. Mahley Karl H. Weisgraber Stefano Bellosta Robert E. Pitas Dale Newland Britto P. Nathan Steven J. Smith Tony Wyss‐Coray
Journals: Journal of Biological Chemistry (10 papers)Journal of Clinical Investigation (7 papers)Proceedings of the National Academy of Sciences (4 papers)The Journal of Cell Biology (2 papers)Journal of Lipid Research (2 papers)
Partner nations: United States Japan South Africa

In The Last Decade

David A. Sanan

41 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat 2000 · 716 citations

Peers

Countries citing papers authored by David A. Sanan

Since Specialization

Citations

This map shows the geographic impact of David A. Sanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Sanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Sanan more than expected).

Fields of papers citing papers by David A. Sanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Sanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Sanan. The network helps show where David A. Sanan may publish in the future.

Co-authors

The 25 scholars most cited alongside David A. Sanan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Sanan Line = papers co-authored together David A. Sanan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Hepatocyte-derived ApoE Is More Effective than Non-hepatocyte-derived ApoE in Remnant Lipoprotein Clearance Journal of Biological Chemistry ·Robert L. Raffaı̈, Alyssa H. Hasty, Yuwei Wang, Shelley Mettler, David A. Sanan, MacRae F. Linton, Sergio Fazio, Karl H. Weisgraber	2003	28
2	Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice Proceedings of the National Academy of Sciences ·Emily L. Willner, Bryan Tow, Kimberly K. Buhman, Martha D. Wilson, David A. Sanan, Lawrence L. Rudel, Robert V. Farese	2003	149
3	Defining the Importance of Phosphatidylserine Synthase 2 in Mice Journal of Biological Chemistry ·Martin O. Bergö, Bryant J. Gavino, Renske D.M. Steenbergen, Bénédicte Sturbois, Albert F. Parlow, David A. Sanan, William C. Skarnes, Jean E. Vance, Stephen G. Young	2002	79
4	Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons Proceedings of the National Academy of Sciences ·Yadong Huang, Xiaoqin Liu, Tony Wyss‐Coray, Walter J. Brecht, David A. Sanan, Robert W. Mahley	2001	311
5	Chronic Overproduction of Transforming Growth Factor-β1 by Astrocytes Promotes Alzheimer's Disease-Like Microvascular Degeneration in Transgenic Mice American Journal Of Pathology ·Tony Wyss‐Coray, Carol Lin, David A. Sanan, Lennart Mucke, Eliezer Masliah	2000	197
6	Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1 Journal of Clinical Investigation ·Michel Accad, Steven J. Smith, Dale Newland, David A. Sanan, Lloyd E. King, MacRae F. Linton, Sergio Fazio, Robert V. Farese	2000	196
7	Isolation and Characterization of Apolipoproteins from Murine Microglia Journal of Biological Chemistry ·Qiang Xu, Yonghong Li, Connie Cyras, David A. Sanan, Barbara Cordell	2000	57
8	Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat Nature Genetics ·Steven J. Smith, Sylvaine Cases, Dalan R. Jensen, Hubert C. Chen, Eric Sande, Bryan Tow, David A. Sanan, Jacob Raber, Robert H. Eckel, Robert V. Farese Hit paper breakdown →	2000	716
9	Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. Journal of Clinical Investigation ·Jianglin Fan, Z S Ji, Yi Huang, H de Silva, David A. Sanan, Robert W. Mahley, T L Innerarity, John M. Taylor	1998	70
10	Overexpression of Hepatic Lipase in Transgenic Mice Decreases Apolipoprotein B-containing and High Density Lipoproteins Journal of Biological Chemistry ·Helén L. Dichek, Walter J. Brecht, Jianglin Fan, Zhong-Sheng Ji, Sally P.A. McCormick, Hassibullah Akeefe, Lorianna Conzo, David A. Sanan, Karl H. Weisgraber, Stephen G. Young, John M. Taylor, Robert W. Mahley	1998	94
11	Role of Actin-binding Protein in Insertion of Adhesion Receptors into the Membrane Journal of Biological Chemistry ·Sylvie C. Meyer, David A. Sanan, Joan E.B. Fox	1998	45
12	Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Journal of Clinical Investigation ·Murielle M. Véniant, Vincenzo Pierotti, Dale Newland, C M Cham, David A. Sanan, Rosemary L. Walzem, Stephen G. Young	1997	86
13	Apolipoprotein E2 Transgenic Rabbits Journal of Biological Chemistry ·Yadong Huang, Susan W. Schwendner, Stanley C. Rall, David A. Sanan, Robert W. Mahley	1997	45
14	The Platelet Cytoskeleton Stabilizes the Interaction between αⅡbβ3 and Its Ligand and Induces Selective Movements of Ligand-occupied Integrin Journal of Biological Chemistry ·Joan E.B. Fox, Sanford J. Shattil, R L Kinlough-Rathbone, Mary Richardson, Marian A. Packham, David A. Sanan	1996	66
15	Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. Journal of Clinical Investigation ·D A Purcell-Huynh, Robert V. Farese, David Johnson, L. M. Flynn, Vincenzo Pierotti, Dale Newland, MacRae F. Linton, David A. Sanan, Stephen G. Young	1995	163
16	Expression of Platelet Glycoprotein (GP) V in Heterologous Cells and Evidence for Its Association with GP Ibα in Forming a GP Ib-IX-V Complex on the Cell Surface Journal of Biological Chemistry ·Chester Q. Li, Jing-fei Dong, François Lanza, David A. Sanan, Garunee Sae-Tung, José A. López	1995	122
17	Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. Journal of Clinical Investigation ·A Boylan, David A. Sanan, Dean Sheppard, V. Courtney Broaddus	1995	68
18	Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. Journal of Clinical Investigation ·Stefano Bellosta, Robert W. Mahley, David A. Sanan, J Murata, Dale Newland, John M. Taylor, Robert E. Pitas	1995	251
19	Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. Journal of Clinical Investigation ·David A. Sanan, Karl H. Weisgraber, Stephen J. Russell, Robert W. Mahley, David Huang, Ann M. Saunders, D. E. Schmechel, Thomas Wısnıewskı, Blas Frangione, Allen D. Roses	1994	335
20	Simultaneous visualization of LDL receptor distribution and clathrin lattices on membranes torn from the upper surface of cultured cells. Journal of Histochemistry & Cytochemistry ·David A. Sanan, R G Anderson	1991	89

About David A. Sanan

David A. Sanan is a scholar working on Immunology and Allergy, Hematology, Neurology, Physiology and Biochemistry, having authored 41 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (6 papers), Lipoproteins and Cardiovascular Health (6 papers), Alzheimer's disease research and treatments (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Platelet Disorders and Treatments (5 papers), Animal Genetics and Reproduction (4 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Biochemistry (719 citations), Physiology (1.6k citations), Neurology (289 citations), Endocrinology, Diabetes and Metabolism (582 citations) and Biochemistry (208 citations). David A. Sanan has collaborated with scholars based in United States, Japan and South Africa. Frequent co-authors include Robert W. Mahley, Karl H. Weisgraber, Stefano Bellosta, Robert E. Pitas, Dale Newland, Britto P. Nathan, Steven J. Smith, Tony Wyss‐Coray, Robert V. Farese and Hubert C. Chen. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Journal of Lipid Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact